141 related articles for article (PubMed ID: 7506988)
1. Alpha-fetoprotein glycosylation is abnormal in some hepatocellular carcinoma, including white patients with a normal alpha-fetoprotein concentration.
Ajdukiewicz AB; Kelleher PC; Krawitt EL; Walters CJ; Mason PB; Koff RS; Bélanger L
Cancer Lett; 1993 Oct; 74(1-2):43-50. PubMed ID: 7506988
[TBL] [Abstract][Full Text] [Related]
2. Altered glycosylation of alpha-fetoprotein in hepadnavirus-induced hepatocellular carcinoma of the woodchuck.
Kelleher PC; Walters CJ; Myhre BD; Tennant BC; Gerin JL; Cote PJ
Cancer Lett; 1992 Apr; 63(2):93-9. PubMed ID: 1373341
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
Khien VV; Mao HV; Chinh TT; Ha PT; Bang MH; Lac BV; Hop TV; Tuan NA; Don LV; Taketa K; Satomura S
Int J Biol Markers; 2001; 16(2):105-11. PubMed ID: 11471892
[TBL] [Abstract][Full Text] [Related]
4. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
Naitoh A; Aoyagi Y; Asakura H
J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
[TBL] [Abstract][Full Text] [Related]
5. Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
van Staden L; Bukofzer S; Kew MC; Savage N
J Gastroenterol Hepatol; 1992; 7(3):260-5. PubMed ID: 1377039
[TBL] [Abstract][Full Text] [Related]
6. Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Kuromatsu R; Tanaka M; Tanikawa K
Liver; 1993 Aug; 13(4):177-82. PubMed ID: 7690873
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Yamashiki N; Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Inoue K; Okamura A; Arita S; Harada K
Oncol Rep; 1999; 6(6):1229-32. PubMed ID: 10523686
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Fucose-Specific Lectins to Improve Quantitative AFP-L3 Assay for Diagnosing Hepatocellular Carcinoma Using Mass Spectrometry.
Lee J; Yeo I; Kim Y; Shin D; Kim J; Kim Y; Lim YS; Kim Y
J Proteome Res; 2022 Jun; 21(6):1548-1557. PubMed ID: 35536554
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in alpha-fetoprotein testing and alpha-fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients.
Wu G; Wu J; Pan X; Liu B; Yao Z; Guo Y; Shi X; Ding Y
Cancer Med; 2019 Nov; 8(15):6614-6623. PubMed ID: 31517445
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Yoshida S; Kurokohchi K; Arima K; Masaki T; Hosomi N; Funaki T; Murota M; Kita Y; Watanabe S; Kuriyama S
Int J Oncol; 2002 Feb; 20(2):305-9. PubMed ID: 11788893
[TBL] [Abstract][Full Text] [Related]
11. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.
Li D; Mallory T; Satomura S
Clin Chim Acta; 2001 Nov; 313(1-2):15-9. PubMed ID: 11694234
[TBL] [Abstract][Full Text] [Related]
12. Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Du MQ; Hutchinson WL; Johnson PJ; Williams R
Cancer; 1991 Jan; 67(2):476-80. PubMed ID: 1702350
[TBL] [Abstract][Full Text] [Related]
13. Interaction of lectins with their ligand carbohydrate of alpha-fetoprotein: analysis by mixed-lectin affinity electrophoresis.
Taketa K; Liu M; Taga H
Electrophoresis; 1996 Mar; 17(3):483-8. PubMed ID: 8740163
[TBL] [Abstract][Full Text] [Related]
14. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
15. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
[TBL] [Abstract][Full Text] [Related]
16. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.
Yamashita F; Tanaka M; Satomura S; Tanikawa K
Gastroenterology; 1996 Oct; 111(4):996-1001. PubMed ID: 8831594
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Lens culinaris agglutinin reactive alpha-fetoprotein and biological features of hepatocellular carcinoma.
Kusaba T
Kurume Med J; 1998; 45(1):113-20. PubMed ID: 9658760
[TBL] [Abstract][Full Text] [Related]
20. Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.
Morimoto M; Numata K; Nozaki A; Kondo M; Moriya S; Taguri M; Morita S; Konno M; Sugo A; Miyajima E; Maeda S; Tanaka K
Int J Clin Oncol; 2012 Aug; 17(4):373-9. PubMed ID: 21847534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
